Ultra-fast deep-learned CNS tumour classification during surgery
C. Vermeulen,
M. Pagès-Gallego,
L. Kester,
M. E. G. Kranendonk,
P. Wesseling,
N. Verburg,
P. Witt Hamer,
E. J. Kooi,
L. Dankmeijer,
J. Lugt,
K. Baarsen,
E. W. Hoving,
B. B. J. Tops () and
J. Ridder ()
Additional contact information
C. Vermeulen: Oncode Institute
M. Pagès-Gallego: Oncode Institute
L. Kester: Princess Máxima Center for Pediatric Oncology
M. E. G. Kranendonk: Princess Máxima Center for Pediatric Oncology
P. Wesseling: Princess Máxima Center for Pediatric Oncology
N. Verburg: Amsterdam University Medical Centers/VUmc
P. Witt Hamer: Amsterdam University Medical Centers/VUmc
E. J. Kooi: Amsterdam University Medical Centers/VUmc
L. Dankmeijer: Amsterdam University Medical Centers/VUmc
J. Lugt: Princess Máxima Center for Pediatric Oncology
K. Baarsen: Princess Máxima Center for Pediatric Oncology
E. W. Hoving: Princess Máxima Center for Pediatric Oncology
B. B. J. Tops: Princess Máxima Center for Pediatric Oncology
J. Ridder: Oncode Institute
Nature, 2023, vol. 622, issue 7984, 842-849
Abstract:
Abstract Central nervous system tumours represent one of the most lethal cancer types, particularly among children1. Primary treatment includes neurosurgical resection of the tumour, in which a delicate balance must be struck between maximizing the extent of resection and minimizing risk of neurological damage and comorbidity2,3. However, surgeons have limited knowledge of the precise tumour type prior to surgery. Current standard practice relies on preoperative imaging and intraoperative histological analysis, but these are not always conclusive and occasionally wrong. Using rapid nanopore sequencing, a sparse methylation profile can be obtained during surgery4. Here we developed Sturgeon, a patient-agnostic transfer-learned neural network, to enable molecular subclassification of central nervous system tumours based on such sparse profiles. Sturgeon delivered an accurate diagnosis within 40 minutes after starting sequencing in 45 out of 50 retrospectively sequenced samples (abstaining from diagnosis of the other 5 samples). Furthermore, we demonstrated its applicability in real time during 25 surgeries, achieving a diagnostic turnaround time of less than 90 min. Of these, 18 (72%) diagnoses were correct and 7 did not reach the required confidence threshold. We conclude that machine-learned diagnosis based on low-cost intraoperative sequencing can assist neurosurgical decision-making, potentially preventing neurological comorbidity and avoiding additional surgeries.
Date: 2023
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/s41586-023-06615-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:622:y:2023:i:7984:d:10.1038_s41586-023-06615-2
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/s41586-023-06615-2
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().